AJOVY™ Financial Assistance Guide
CHAMP has created the financial assistance guide below for anyone who has been prescribed AJOVY™ by their healthcare provider. AJOVY™ is one of three new CGRP inhibitors that were approved for the prevention of migraine in adults. If you or someone you know requires help with paying for treatment, please review the details provided below to see if you qualify for the manufacturer’s financial assistance programs and how best to access AJOVY™.
Please note: This guide has not been produced or approved by the manufacturer of AJOVY™. CHAMP does not endorse the use of any CGRP inhibitor over another, nor promote the use of this new class of preventive medications for everyone with migraine disease. Please consult your healthcare provider to determine if CGRP inhibitors are right for you.
Many insurers have not yet decided if or how they will cover the costs of these CGRP inhibitors. If you are prescribed a CGRP inhibitor, each pharmaceutical company is offering financial assistance programs to help cover the costs. Each program is different and various programs exist to support patients with private or public insurance, as well as the uninsured.
To help patients understand each program, the Coalition For Headache And Migraine Patients (CHAMP) has created Financial Assistance Guides for the three CGRP inhibitors. These guides have not been produced or approved by the medication manufacturers. CHAMP is not endorsing the use of any CGRP inhibitor over another, nor promoting the use of this new class of preventive medications for everyone with migraine disease. Every patient needs to consult their healthcare provider to determine if CGRP inhibitors are right for you.
I Have Been Prescribed AJOVY™. What Financial Assistance Programs Exits To Help Me?
I Have a Private/Commercial Insurance Plan
This category includes insurance plans provided through an employer, purchased with subsidy support from the Affordable Care Act (Obamacare) or purchased privately.
Highlights of Teva Savings Card
- No registration or activation is needed to use the Savings Offer for AJOVY™.
- If your health plan does not cover AJOVY™, you can use the Savings Offer and pay as little as $0 on each prescription until the offer expires at the end of 2019.
- There is no annual cap or maximum benefit for the Savings Offer.
Details about the Savings Offer program for 2020 and beyond are not yet available.
Congratulations on accessing your first dose of AJOVY™! Teva will now be working behind the scenes to get your doctor to complete a prior authorization form and to get your insurance company to cover your AJOVY™ prescription. To be a proactive and engaged patient, you should contact your doctor's office to see if they have completed the AJOVY™ prior authorization form on your behalf and your insurance company to see if they will be covering your prescribed medicine. If you have questions or encounter problems, contact Teva Shared Solutions at 1-800-887-8100.
I Have Medicare, Medicaid or other Government Insurance Plan
The Teva Savings Offer is not available to patients whose medical insurance is provided by state or federal programs, like Medicare and Medicaid. This restriction is true for all three CGRP inhibitor medications.
The Federal Government does not allow people who are receiving insurance benefits through Medicare, Medicaid, etc. to use co-pay assistance, discount or savings cards offered by pharmaceutical companies. The intent is to steer patients to lower-cost generic drugs and not to support higher-cost brand-name drugs. Unfortunately, there are no generic/biosimilar medications in the class of CGRP inhibitors and won’t be for years to come.
If you are struggling to get Medicare or Medicaid to cover your prescription, speak to a Teva Shared Solutions representative at 1-800-887-8100 who will help determine eligibility for available financial assistance programs. The call center is open Monday – Friday, 9 a.m. – 9 p.m. ET.
I Am Uninsured
The Teva Savings Offer is not available to patients who are uninsured.
The TevaCares Foundation Patient Assistance Program offers financial assistance to uninsured and underinsured patients with lower incomes. Income eligibility can cover households earning up to 500% of the Federal Poverty Level (about $60,000 for singles or up to $125,000 for a family of four). Speak to a Shared Solutions® representative at 1-800-887-8100 to determine if you are eligible. The call center is open Monday – Friday, 9 a.m. – 9 p.m. ET.
Where do I turn if I need more help accessing this medicine?
The Patient Advocate Foundation (a CHAMP member organization) can be a helpful resource for patients and caregivers who are experiencing access challenges. PAF provides a suite of expert tips to help navigate insurance denials, appeals and common barriers at: patientadvocate.org/migrainematters.
PAF also offers direct case management services to patients with treatment access issues or financial challenges. Call 1-800-532-5274 to connect with support or visit: patientadvocate.org/gethelp.
|Dosing & Administration||Option 1: 225 mg monthly administered as one subcutaneous injection.|
Option 2: 675 mg (3x 225mg) every three months (quarterly), administered as three subcutaneous injections.
Your doctor will determine which option is best for you.
|Indication||Adults living with either chronic migraine (15 or more headache days per month) or episodic migraine (fewer than 15 headache days per month).|
|Full Prescribing Information||https://www.ajovy.com/globalassets/ajovy/ajovy-pi.pdf|
|Helpline||Teva Shared Solutions® at 1-800-887-8100.|
|Injection Training Available||Yes, in-person injection training is available.|
|Sharps Container Available||No, but a guide on how to properly dispose of a used syringe is available on the Ajovy website.|
|Home Delivery Available||Yes, home delivery is an option through Teva Shared Solutions Pharmacy, which will coordinate the delivery of the refrigerated medication.|